Literature DB >> 6416520

Primary hyperparathyroidism: the case for medical management.

W Van'T Hoff, F W Ballardie, E J Bicknell.   

Abstract

Thirty two patients with primary hyperparathyroidism were followed up medically for a mean of 4.2 years. One patient had an operation because of a rise in plasma calcium concentration. There was no significant change in the mean plasma calcium and creatinine concentrations or in blood pressure during the period of follow up. The progress of these patients who were managed medically was compared with that of a group of 60 patients who had had successful operations for primary hyperparathyroidism. There was no significant change in mean plasma creatinine concentration or in blood pressure in the group who had had operations during a mean follow up period of 5.9 years. The natural history of mild asymptomatic hyperparathyroidism is probably different from and better than that of the type of hyperparathyroidism that was usually seen before the advent of routine chemical screening. It is suggested that patients over the age of 60 with mild asymptomatic hyperparathyroidism, and perhaps even younger patients, may not require operation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416520      PMCID: PMC1549790          DOI: 10.1136/bmj.287.6405.1605

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  The aetiology of essential hypertension. I. The arterial pressure in the general population.

Authors:  M HAMILTON; G W PICKERING; J A F ROBERTS; G S SOWRY
Journal:  Clin Sci       Date:  1954-02       Impact factor: 6.124

Review 2.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Treatment of primary hyperparathyroidism.

Authors:  D C Purnell; D A Scholz; L H Smith; G W Sizemore; M B Black; R S Goldsmith; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

4.  Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects.

Authors:  R C Haff; W C Black; W F Ballinger
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

5.  Calcareous renal disease and hyperparathyroidism.

Authors:  J M George; A S Rabson; A Ketcham; F C Bartter
Journal:  Q J Med       Date:  1965-07

6.  Creatinine clearance, different methods of determination.

Authors:  J A Thomis; H H Soep; T Hallynck; J Boelaert; R Daneels; L Dettli
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

7.  Hyperparathyroidism: experiences with treated and untreated patients.

Authors:  P G Rohl; M Wilkinson; P Clifton-Bligh; S Posen
Journal:  Med J Aust       Date:  1981-05-16       Impact factor: 7.738

8.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

9.  Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile.

Authors:  J S Harrop; J E Bailey; J S Woodhead
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

10.  Conservative management of primary hyperparathyroidism.

Authors:  P H Adams
Journal:  J R Coll Physicians Lond       Date:  1982-07
View more
  10 in total

1.  Hypercalcaemia in rheumatoid arthritis revisited.

Authors:  S H Ralston; W D Fraser; J Jankowski; I M Richards; R A Cowan; H A Capell; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

2.  Treatment for mild hyperparathyroidism.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-14

3.  Time to end a conservative treatment for mild hyperparathyroidism.

Authors:  J C Stevenson; J A Lynn
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

4.  Long term follow up of untreated primary hyperparathyroidism.

Authors:  C Nagant de Deuxchaisnes; J P Devogelaer; J P Huaux
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

5.  Asymptomatic parathyroid adenoma manifested by intratumoral hemorrhage.

Authors:  A Paracchi; E Reschini; C Ferrari; R Macchi
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

6.  Long term follow up of untreated primary hyperparathyroidism.

Authors:  C R Paterson; J Burns; E Mowat
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

7.  Acute complications in the course of "mild" hyperparathyroidism.

Authors:  S M Corsello; G Folli; F Crucitti; S Della Casa; C A Rota; A Tofani; S Colasanti; A Barbarino
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

8.  Hypercalcaemia in Cleveland: a hospital-based survey.

Authors:  A Rajathurai; R Cove-Smith
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

9.  The influence of surgery on the risk of death in patients with primary hyperparathyroidism.

Authors:  G Hedbäck; A Odén; L E Tisell
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

10.  Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension.

Authors:  J J Sancho; J Rouco; R Riera-Vidal; A Sitges-Serra
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.